Françoise J. Gellibert
Institut de Recherches Internationales Servier (France) · 15 works · 1,794 citations · h-index 13
Top works
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
- Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
- Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors
- Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis
- Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
- From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
- Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor
- Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents
- Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors
- Inhibition of ALK5 Signaling Induces Physeal Dysplasia in Rats
- Deep generative models for ligand‐based de novo design applied to multi‐parametric optimization
- Comparison of Soluble Guanylate Cyclase Stimulators and Activators in Models of Cardiovascular Disease Associated with Oxidative Stress
- Naphthyridines as Novel BET Family Bromodomain Inhibitors
- Synthese d'analogues structuraux a motif captodatif et de nouveaux metabolites de l'acide arachidonique : actions sur la 5-lipoxygenase
- The first bromodomain of human BRD4 in complex with 3,5 dimethylisoxaxole ligand